New Hope for Lung Cancer Patients

Monday, 03 Jun 2013 12:44 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

A drug designed to block a protein known to help cancer cells grow was shown in a mid-stage trial to lengthen survival in patients with advanced lung cancer that worsened after initial treatment, researchers said on Monday.
 
The results, presented at a meeting of the American Society of Clinical Oncology in Chicago, are the first time an agent in a class known as heat shock protein 90 inhibitors, HSP90 for short, has been shown to be safe and effective, they said.
 
Ganetespib, developed by Synta Pharmaceuticals, is designed to block HSP90, serving to knock out a pathway used by many different cancer-fueling proteins.
 
The Phase 2 trial, conducted by researchers from the Winship Cancer Institute of Emory University in Atlanta, involved 252 patients with late-stage lung adenocarcinoma, the most common type of lung cancer. It accounts for about 45 percent of the 170,000 non-small cell lung cancer cases diagnosed in the United States each year.
 
The study compared treatment with a combination of ganetespib and chemotherapy to chemotherapy alone. Patients on the drug lived for a median of 9.8 months, compared with 7.4 months for patients given just chemotherapy.
 
For patients whose cancer was diagnosed six months or more before the start of the study, overall survival improved to 10.7 months compared with 6.4 months - a gain of 67 percent.
That group of patients is being studied in a pivotal trial of ganetespib.
 
Side effects associated with the drug included low white blood cell levels, fatigue and diarrhea.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Two Ebola Patients Coming to US

Friday, 01 Aug 2014 17:12 PM

Two American aid workers, both seriously ill after being infected with the deadly Ebola virus in Liberia, will be flown  . . .

New Type 2 Diabetes Drug Gets FDA OK

Friday, 01 Aug 2014 16:11 PM

The U.S. Food and Drug Administration announced on Friday that itapproved a new drug, Jardiance, to help fight Type 2 di . . .

Why Isn't There a Vaccine or Treatment for Ebola?

Friday, 01 Aug 2014 16:01 PM

In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no li . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved